© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Weight Loss Achievable Despite Interruptions in GLP-1 Medication Access, Study Finds
July 16, 2025
ENDO 2025. People with inconsistent access to GLP-1 medications still achieved clinically significant weight loss when therapy was combined with lifestyle changes and coaching.
New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism
July 16, 2025
ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.
Obesity Redefined: 1 in 5 Adults Reclassified Under New EASO Criteria
July 16, 2025
Individuals newly classified with obesity using the European framework were found to be overall sicker and at greater risk for mortality.
Q&A: GLP-1 Monotherapy Is Not Enough—Jonathan Bonnet, MD, MPH, on the Lifestyle Prescription for Obesity
July 15, 2025
Obesity medicine expert Bonnet answers questions about the downsides of GLP-1 therapy for obesity management and how lifestyle medicine interventions will help.
"Everyone is a Candidate for Some Positive Lifestyle Change," Guideline Author Suggests
July 15, 2025
Richard Rosenfeld, MD, MPH, MBA, led the development of lifestyle medicine guidelines to treat or even reverse prediabetes and type 2 diabetes.
Population-Wide Study Finds No Link Between Aluminum Exposure in Vaccines and Childhood Disorders
July 15, 2025
The Danish study analyzed a nationwide cohort of 2.1 million children and found no association between aluminum exposure and allergic, autoimmune, or neurodevelopmental conditions.
ENDO 2025: Most Patients With Classic Congenital Adrenal Hyperplasia Experience High Glucocorticoid Exposure or Suboptimal Control
July 15, 2025
A new analysis of the CAHtalog phase 3 study showed approximately 95% of participants experienced either high glucocorticoid exposure or elevated androstenedione levels during treatment.
The Role of Stress Reduction in Cardiometabolic Disease Management for Patients with Obesity
July 15, 2025
Monu Khanna, MD, discusses the benefits of behavioral strategies, including yoga, breathwork, and dancing, in reducing cardiovascular disease risk in patients with obesity.
Turn Therapeutics Launches First Clinical Trial to Assess Topical IL-36 Inhibitor for Atopic Dermatitis
July 15, 2025
GX-03 has proven effective in preclinical trials, reducing disease severity by more than 50% vs placebo. Data from the current study are expected by year end.
Maternal Depression Impairs Parental Emotional Responsiveness, Daily Care for Infants, Children: Global Systematic Review
July 15, 2025
Maternal depression significantly disrupts parenting behaviors, impacting child development and emotional bonding, according to an updated international literature review.